Megan L. Campbell

Megan L. Campbell

Auto-generated profile, based on publicly available information

Megan L. Campbell

OrthoCarolina Foot & Ankle Institute, Charlotte, NC, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2022 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
HMHiroko Matsumoto
Hiroko Matsumoto
ABAfrain Z. Boby
Afrain Z. Boby
RSRishi Sinha
Rishi Sinha
MCMegan L. Campbell
Megan L. Campbell
CHChun Wai Hung
Chun Wai Hung
MVMichael G. Vitale
Michael G. Vitale
Background: The 24-question Early-Onset Scoliosis Questionnaire (EOSQ-24) is a proxy measure assessing health-related quality of life (HRQoL) among patients with early-onset scoliosis (EOS). There exists an increasing need to assess HRQoL through a child’s own perspective, particularly for older children and adolescents with EOS. The purpose of this study was to develop and validate a self-reported questionnaire, the Early-Onset Scoliosis Self-Report Questionnaire (EOSQ-SELF), to assess HRQoL in older children and adolescents with EOS. Methods: A literature review, an expert focus group, and patient interviews were used to generate a preliminary survey of appropriate domains and question items. This survey was provided to English-speaking patients with EOS who were 8 to 18 years of age and capable of answering survey questions. Content validity was assessed for clarity and relevance of questions. Confirmatory factors analysis was performed to reduce the number of items and determine domains that fit items. Reliability was evaluated by measuring the internal consistency of items and test-retest reliability. Construct validity was evaluated by convergent, discriminant, and known-group validity. Results: The literature review, expert focus group, and patient interviews identified 59 questions in 14 domains. Psychometric analysis reduced these to 30 questions across 12 domains: General Health, Pain/Discomfort, Pulmonary Function, Transfer, Physical Function/Daily Living, Participation, Fatigue/Energy Level, Sleep, Appearance, Relationships, Emotion, and Satisfaction. The final questionnaire was found to have good content and construct validity and adequate reliability. Conclusions: The EOSQ-SELF is a valid and reliable instrument for measuring self-reported HRQoL among older children and adolescents with EOS (ages 8 to 18 years). This will serve as an important research outcome measure and enhance clinical care by providing a better understanding of HRQoL for these patients. Level of Evidence: Diagnostic Level II . See Instructions for Authors for a complete description of levels of evidence.

1 March 2020 in JBJS Reviews
Verified
Journal Article
Closed access
HMHiroko Matsumoto
Hiroko Matsumoto
MSMatthew E. Simhon
Matthew E. Simhon
MCMegan L. Campbell
Megan L. Campbell
MVMichael G. Vitale
Michael G. Vitale
ELElaine L. Larson
Elaine L. Larson
Background: Considerable variation exists in surgical site infection (SSI) prevention practices for pediatric patients undergoing spinal deformity surgery, but the incidence of SSI has been reported to remain high in the United States. The literature reports various risk factors associated with SSI but findings are inconsistent. The purpose of this systematic review and meta-analysis was to assess the published literature investigating associations between various risk factors and SSI in pediatric patients undergoing spinal surgery. Methods: The systematic review and the meta-analysis were conducted according to Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) guidelines among peer-reviewed journals published in English between January 2000 and April 2019. Studies that involved pediatric patients with spinal deformity undergoing surgical procedures in North America and assessed risk factors for SSI were included. The quality of individual studies was assessed, and weighted risk ratios and mean differences were calculated for each risk factor. Results: Of 763 potential articles identified, 13 met inclusion criteria; 7 studies were rated as average and 6, as poor quality based on the quality checklist. The meta-analysis demonstrated that the SSI risk increased by the following factors: 2.53 (95% confidence interval [CI], 1.26 to 5.10) for overweight to obese patients compared with patients with normal weight, 2.84 (95% CI, 1.67 to 4.81) for patients with a neuromuscular etiology compared with non-neuromuscular etiology, 1.69 (95% CI, 1.41 to 2.02) for patients with a gastrostomy tube (G-tube) compared with those without, 3.45 (95% CI, 2.08 to 5.72) for nonambulatory patients compared with ambulators, and 3.39 (95% CI, 2.38 to 4.83) for patients with pelvic instrumentation compared with those without. Patients who developed SSI also had 158.38 mL (95% CI, 46.78 to 269.97 mL) greater estimated blood loss compared with those who did not. Conclusions: Despite the limited quality of the available studies and wide variety of populations and outcome definitions, evidence suggests that overweight to obese status, neuromuscular etiology, use of a G-tube, nonambulatory status, instrumentation to the pelvis, and greater estimated blood loss are risk factors for SSI. The use of a common SSI definition and strong methodology are warranted for future studies. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete list of levels of evidence.

1 March 2022 in Injury
Verified
Journal Article
Closed access
GDGraham J. DeKeyser
Graham J. DeKeyser
MCMegan L. Campbell
Megan L. Campbell
PKPatrick J. Kellam
Patrick J. Kellam
JHJustin M. Haller
Justin M. Haller
DRDavid L. Rothberg
David L. Rothberg
LMLucas S. Marchand
Lucas S. Marchand

1 August 2025 in Journal of Orthopaedic Trauma
Verified
Journal Article
Closed access
MCMegan L. Campbell
Megan L. Campbell
OSOliver C. Sroka
Oliver C. Sroka
TTTyler Thorne
Tyler Thorne
AHAnne Hakim
Anne Hakim
MSMatthew J. Siebert
Matthew J. Siebert
LMLucas S. Marchand
Lucas S. Marchand
OBJECTIVES: To determine the incidence and risk factors for secondary arthrodesis (SA) and compare patients who underwent primary arthrodesis (PA) vs. SA after open reduction and internal fixation (ORIF) for Lisfranc injuries. METHODS: Design: Retrospective cohort. Setting: Single tertiary level 1 trauma center Patient Selection Criteria: Adult patients treated surgically for Lisfranc injuries (AO/OTA 85.1A-C ± 85.2A-C, 85.3A-C; 87.1.1A-C-87.5.1A-C; 89B) between 2003 and 2023 were included. Outcome Measures and Comparisons: Patients who underwent index PA were compared with those who underwent index ORIF and subsequent SA. A composite primary outcome was used for comparison that included the development of adjacent midfoot arthrosis; midfoot collapse; or mal/nonunion rated satisfactory, suboptimal, poor, or severe; secondary outcomes were Patient Reported Outcome Measurement Information System measures of physical function (PF) and pain interference (PI). Descriptive and comparative statistics, multivariable analysis, and logistic regression were used to compare groups. RESULTS: Of 489 Lisfranc injuries (482 patients), index treatment for 98 (20%) was PA. Average age was 37.7 y (SD 15.6); mean follow-up was 2.3 y (SD 8.8). Fifty six percent of patients were men. There were 34 SAs (8.7% of index ORIF group). Patients who underwent SA were more likely to develop a poor (21.9% vs. 6.5% P = 0.021) or severe outcome (12.5% vs. 1.1%, P = 0.015) compared with those who underwent PA (OR 5.1, CI 1.4–18.5; OR 12.7, CI 1.1–12.8). Patients requiring SA also had significantly higher PI and significantly lower PF at final follow-up (P = 0.018, P < 0.001). Divergent injuries had higher odds of needing an SA than homolateral injuries (OR 6.9, P = 0.006), as did index treatment with a tightrope (OR 4.6, P = 0.003). CONCLUSIONS: Nine percent of patients underwent SA after index ORIF of their Lisfranc injury, and outcomes fared substantially worse than those treated with PA. This emphasizes the importance of identifying risk factors for patients that may fail ORIF. Further work is needed to clearly delineate which patients may best be served with PA. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 April 2019 in JBJS Case Connector
Verified
Journal Article
Closed access
MCMegan Campbell
Megan Campbell
BFBensen Fan
Bensen Fan
BGBalazs Galdi
Balazs Galdi
Case: A 30-year-old man was found to have a posteriorly displaced osteochondral shear fracture of his left humeral head, likely from dislocation and relocation. The fragment was fixed in its native position using headless screws, and the patient regained full strength and range of motion within 9 months. Conclusions: Osteochondral shear fractures of the humeral head appear to shear off the anteromedial articular joint surface after dislocation and relocation. One should be suspicious for associated labral tears. Arthroplasty is a valid treatment option, but select patients may be eligible for other viable options.

12 February 2026 in Foot & Ankle International
Verified
Journal Article
Closed access
MCMegan Campbell
Megan Campbell
CCCalvin Chandler
Calvin Chandler
JBJoseph Burger
Joseph Burger
BHBlake Hodgens
Blake Hodgens
WTWilliam Teachey
William Teachey
SFSamuel Ford
Samuel Ford
Background: As total ankle arthroplasty (TAA) use evolves, understanding implant longevity and survivorship expectations has become critical for patient counseling and decision making. The purpose of this study was to determine the long-term survivorship of the INBONE II TAA. Methods: Patients enrolled in a prospective single-institution TAA registry with minimum 10-year follow-up after INBONE II TAA were retrospectively identified. Chart review captured operative data, prior and concomitant surgeries, reoperations, and revision details. Pre- and postoperative radiographs were measured to assess alignment and periprosthetic lucency or osteolysis. Survivorship was determined by incidence and timing of metal component revision (MCR). Data were stratified by those who failed (MCR) and those who did not. Of 180 TAAs, 74 ankles (71 patients) met inclusion criteria. Results: Mean age at surgery was 60.9 years (38.7-78.4), with median 10.4 years of follow-up (IQR 9.8, 11.1). Survivorship at minimum 10 years was 93.2% (95% CI: 87.1%-99.3%). Overall reoperation rate was 16.9%. Peri-implant lucency was found in 28.4% of tibias (21) and 13.5% of taluses (10); cysts were noted in 21.6% of tibias and 12.2% of taluses. The MCR rate was 6.8% (3 talus, 2 both components), secondary to failure of ingrowth (2), osteolysis/polyethylene wear (2), and infection (1). Patients who underwent MCR exhibited numerically greater preoperative varus talar tilt (9.6 vs 2.9 degrees) and varus tibiocalcaneal angle (−5.6 vs 9.1 degrees), although these differences were not statistically significant ( P = .25 and .07, respectively). They also showed larger changes from pre- to postoperative alignment in tibiotalar and distal tibial angles compared with nonfailures (−16.2 vs 0.2 degrees, P = .11; −7.3 vs −0.2 degrees, P = .07), which likewise were not statistically significant. Conclusion: Ten-year survivorship of INBONE II TAA was 93% in this cohort. Despite periprosthetic osteolysis and/or peri-implant lucency, the reoperation rate was low. Although the small number of failures prevented statistically significant conclusions, radiographic patterns suggest possible higher risk of failure in those with greater varus deformity.